Literature DB >> 9593693

Purification, cDNA cloning, and expression of UDP-Gal: glucosylceramide beta-1,4-galactosyltransferase from rat brain.

T Nomura1, M Takizawa, J Aoki, H Arai, K Inoue, E Wakisaka, N Yoshizuka, G Imokawa, N Dohmae, K Takio, M Hattori, N Matsuo.   

Abstract

Lactosylceramide synthase is an enzyme that catalyzes the transfer of galactose from UDP-Gal to glucosylceramide, and thus participates in the biosynthesis of most glycosphingolipids in mammals. We purified this enzyme over 61,000-fold to near homogeneity with a 29. 7% yield from rat brain membrane fractions. The isolation procedure included solubilization with Triton X-100, affinity chromatography on wheat germ agglutinin-agarose and UDP-hexanolamine-agarose, and hydroxylapatite column chromatography, followed by ion exchange chromatography. The final preparation migrated as a broad band with an apparent molecular mass of 61 kDa on SDS-polyacrylamide gel electrophoresis. This apparent molecular mass was reduced to 51 kDa by N-glycanase digestion, suggesting that the enzyme has a glycoprotein nature. The enzyme required Mn2+ for its activity, and glucosylceramide was its preferred substrate. The cDNA for the enzyme was cloned from a rat brain cDNA library. The cDNA insert encoded a polypeptide of 382 amino acid residues, with a molecular weight of 44,776. The polypeptide contained eight putative glycosylation sites and a 20-amino acid residue transmembrane domain at its N terminus. Amino acid sequence homology analysis revealed that this enzyme shared 39% homology with mouse beta-1, 4-galactosyltransferase (EC 2.4.1.38), which catalyzes the transfer of Gal to beta-1,4-GlcNAc in glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593693     DOI: 10.1074/jbc.273.22.13570

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Stage- and tissue-specific expression of a beta-1,4-galactosyltransferase in the embryonic epidermis.

Authors:  K Uehara; J Thelu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-10       Impact factor: 2.416

2.  Involvement of murine β-1,4-galactosyltransferase V in lactosylceramide biosynthesis.

Authors:  Tadahiro Kumagai; Takeshi Sato; Shunji Natsuka; Yukito Kobayashi; Dapeng Zhou; Tadashi Shinkai; Satoru Hayakawa; Kiyoshi Furukawa
Journal:  Glycoconj J       Date:  2010-11-06       Impact factor: 2.916

3.  UDP-N-Acetyl-alpha-D-glucosamine as acceptor substrate of beta-1,4-galactosyltransferase. Enzymatic synthesis of UDP-N-acetyllactosamine.

Authors:  L Elling; A Zervosen; R G Gallego; V Nieder; M Malissard; E G Berger; J F Vliegenthart; J P Kamerling
Journal:  Glycoconj J       Date:  1999-07       Impact factor: 2.916

4.  Harnessing the power of yeast to elucidate the role of sphingolipids in metabolic and signaling processes pertinent to psychiatric disorders.

Authors:  Shyamalagauri Jadhav; Miriam L Greenberg
Journal:  Clin Lipidol       Date:  2014-11-01

5.  Differences in N-acetyllactosamine synthesis between beta-1,4-galactosyltransferases I and V.

Authors:  T Sato; K Furukawa
Journal:  Glycoconj J       Date:  1999-01       Impact factor: 2.916

6.  Quantitative transcriptomic profiling of branching in a glycosphingolipid biosynthetic pathway.

Authors:  Hiromu Takematsu; Harumi Yamamoto; Yuko Naito-Matsui; Reiko Fujinawa; Kouji Tanaka; Yasushi Okuno; Yoshimasa Tanaka; Mamoru Kyogashima; Reiji Kannagi; Yasunori Kozutsumi
Journal:  J Biol Chem       Date:  2011-06-10       Impact factor: 5.157

7.  Identification and characterization of a Drosophila melanogaster ortholog of human beta1,4-galactosyltransferase VII.

Authors:  Nadia Vadaie; Rebecca S Hulinsky; Donald L Jarvis
Journal:  Glycobiology       Date:  2002-10       Impact factor: 4.313

8.  Structural characterization and dynamics of globotetraosylceramide in vascular endothelial cells under TNF-alpha stimulation.

Authors:  Tetsuya Okuda; Sin-ichi Nakakita; Ken-ichi Nakayama
Journal:  Glycoconj J       Date:  2010-02       Impact factor: 2.916

Review 9.  Sphingolipids: the nexus between Gaucher disease and insulin resistance.

Authors:  Maria Fuller
Journal:  Lipids Health Dis       Date:  2010-10-11       Impact factor: 3.876

10.  Golgi targeting of Drosophila melanogaster beta4GalNAcTB requires a DHHC protein family-related protein as a pilot.

Authors:  Anita Johswich; Benjamin Kraft; Manfred Wuhrer; Monika Berger; André M Deelder; Cornelis H Hokke; Rita Gerardy-Schahn; Hans Bakker
Journal:  J Cell Biol       Date:  2009-01-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.